SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 142 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,466 | -26.6% | 92 | -4.2% | 0.00% | – |
Q1 2024 | $4,725 | +40.7% | 96 | +4.3% | 0.00% | – |
Q4 2023 | $3,358 | +202.5% | 92 | +91.7% | 0.00% | – |
Q3 2023 | $1,110 | +135.2% | 48 | +166.7% | 0.00% | – |
Q2 2023 | $472 | -88.2% | 18 | -88.4% | 0.00% | – |
Q1 2023 | $3,990 | +61.5% | 155 | +63.2% | 0.00% | – |
Q4 2022 | $2,471 | +23.6% | 95 | +15.9% | 0.00% | – |
Q3 2022 | $2,000 | – | 82 | +720.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 10 | -90.0% | 0.00% | -100.0% |
Q1 2021 | $7,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |